Lucid Diagnostics Inc. (LUCD) vs Sera Prognostics, Inc. (SERA)
- Lucid Diagnostics Inc. LUCD 0.48 −7.69%
- Sera Prognostics, Inc. SERA 2.06 +1.48%
Lucid Diagnostics Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $105.7M against $80.1M — 1.3× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −35.2%. Lucid Diagnostics Inc. has the higher net margin (−1,193.9% vs −47,475.7%) and the lower return on invested capital (−3,096.5% vs −180.2%). Across the 17 metrics below, Lucid Diagnostics Inc. leads on 10 and Sera Prognostics, Inc. on 7.
Valuation
Profitability
| Metric | LUCD | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | (21.69%) | (150.00%) | 56.01% |
| Operating margin | (930.84%) | (53,282.86%) | (15.03%) |
| Net margin | (1,193.87%) | (47,475.71%) | (20.40%) |
| Free cash flow margin | (866.56%) | (40,760.00%) | (7.24%) |
| Return on equity | 364.89% | (45.03%) | (15.32%) |
| Return on assets | (167.51%) | (33.47%) | (19.72%) |
| Return on invested capital | (3,096.53%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack